Page last updated: 2024-10-23

benzothiazide and Leukemia, Erythroblastic, Acute

benzothiazide has been researched along with Leukemia, Erythroblastic, Acute in 1 studies

benzothiazide: structure
benzthiazide : 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema.

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuppers, DA1
Arora, S1
Lim, Y1
Lim, AR1
Carter, LM1
Corrin, PD1
Plaisier, CL1
Basom, R1
Delrow, JJ1
Wang, S1
Hansen He, H1
Torok-Storb, B1
Hsieh, AC1
Paddison, PJ1

Other Studies

1 other study available for benzothiazide and Leukemia, Erythroblastic, Acute

ArticleYear
N
    Nature communications, 2019, 10-10, Volume: 10, Issue:1

    Topics: Adenosine; Antigens, CD34; Bone Marrow Cells; Cell Cycle Proteins; Cell Line, Tumor; CRISPR-Cas Syst

2019